0

GNF 5837

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1033769286-A
CAS1033769-28-6
Molecular Weight535.49
Description≥98% (HPLC)
SolubilityDMSO: 5 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Coloryellow to orange
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Albumin Hybrid Nanoparticles Loaded With Tyrosine Kinase A Inhibitor GNF-5837 for Targeted Inhibition of Breast Cancer Cell Growth and Invasion

Vahid Heravi Shargh, Hubert Hondermarck, Mingtao Liang

Int J Pharm. 2016 Dec 30;515(1-2):527-534.

PMID: 27793712

1

Discovery of GNF-5837, a Selective TRK Inhibitor With Efficacy in Rodent Cancer Tumor Models

Pam Albaugh, Yi Fan, Yuan Mi, Fangxian Sun, Francisco Adrian, Nanxin Li, Yong Jia, Yelena Sarkisova, Andreas Kreusch, Tami Hood, Min Lu, Guoxun Liu, Shenlin Huang, Zuosheng Liu, Jon Loren, Tove Tuntland, etc.

ACS Med Chem Lett. 2012 Jan 1;3(2):140-5.

PMID: 24900443

1

Gelatin-albumin Hybrid Nanoparticles as Matrix Metalloproteinases-Degradable Delivery Systems for Breast Cancer Therapy

Vahid Heravi Shargh, Hubert Hondermarck, Mingtao Liang

Nanomedicine (Lond). 2017 May;12(9):977-989.

PMID: 28440712

1

Role of NGF-TrkA Signaling in Calcification of Articular Chondrocytes

Yangzi Jiang, Rocky S Tuan

FASEB J. 2019 Sep;33(9):10231-10239.

PMID: 31238006

1

Tropomyosin Receptor Kinase: A Novel Target in Screened Neuroendocrine Tumors

Elke Tatjana Aristizabal Prada, Vera Heinzle, Thomas Knösel, Svenja Nölting, Gerald Spöttl, Julian Maurer, Christine Spitzweg, Martin Angele, Nina Schmidt, Felix Beuschlein, Günter K Stalla, Rainer Blaser, etc.

Endocr Relat Cancer. 2018 May;25(5):547-560.

PMID: 29563190

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode